Project

Structured Medication Reviews

Focus areas:
Locality:
National
Compilation of images of people working in health and social care

Over one million people in England take ten or more medicines for their long term conditions; this is known as polypharmacy. As patients live longer with multiple long term conditions, physiological reserves to cope with taking so many medicines are reduced, and some medicines may present a greater risk to our health as we get older. 16.5% of unplanned admissions to hospital can be attributed to adverse drug reactions with polypharmacy being a key driver. 

Structured medication reviews (SMRs) are NICE-approved and are considered the best tested intervention to reduce problematic polypharmacy, and have been shown to benefit both patients and the NHS. However, it is important that patients understand the SMR and its purpose. Evidence has shown that we need to do more to support patients to understand and make the most of their SMR.


Compilation of images of people working in health and social care

Our impact

National

Over 1 million people

take ten or more medicines for their long term conditions

National

16.5%

of unplanned admissions to hospital can be attributed to adverse drug reactions with polypharmacy being a key driver

National

85%

of primary care network teams agreed that the HIN patient-facing SMR resources helped them engage with seldom-heard communities

Working together with the Health Innovation Network Polypharmacy Programme, Health Innovation Wessex has supported six primary care networks to help seldom heard communities access structured medication reviews (SMRs). 

This project builds on work completed across the Health Innovation Network to use evidence-based materials to invite and support patients to get the most from their SMR. The project has focused on patients living in more deprived areas where studies in Nottingham and Manchester have started to show some important improvements. Work from Scotland, Ireland and in the UK has demonstrated savings not only from stopping inappropriate prescribing but also in wider healthcare utility costs.

View the project summary  

Resources to support patients having a Structured Medication Review

Key findings

Using these materials - which have been designed with patients and tested in primary care networks (PCNs) - increased the uptake of SMRs, reduced 'Did Not Attend' rates, and both clinicians and patients reported that this improved the quality of conversations between patients and their prescriber

Variation was identified in how practices shared patient information resources

Planning the SMR process carefully at practice level is vital

Useful results were achieved with vulnerable groups of patients who may not traditionally engage with Structured Medication Reviews, such as patients who are housebound

Further work needs to be done to understand the relative benefits and downsides of telephone and face to face SMRs.


What's happening nationally?

The Health Innovation Network has published a new report sharing insights and lessons from its initiative to improve access to Structured Medication Reviews for patients in seldom-heard communities, particularly those living in areas of high deprivation and from ethnic minority groups.

The report, based on pilots delivered in 27 primary care networks (PCNs) across England, demonstrates how targeted approaches and dedicated patient resources can increase engagement and attendance at these crucial appointments.

The pilots served as a valuable catalyst for PCNs to refine or establish new SMR pathways. Patient feedback suggests the resources enhance understanding and preparation for reviews, while health and care professionals describe their value in engaging vulnerable populations and improving the quality of consultations, despite challenges related to digital exclusion.

 Key findings

Increased SMR activity: While direct comparison was challenging due to varying study periods, all participating PCNs saw an increase in SMRs completed. Across 27 PCNs, a total of 2,587 SMRs were completed during the study period.

Reduced Did Not Attend (DNA) rates: Most areas were able to demonstrate a clear reduction in DNA rates for SMR appointments.

Improved engagement with seldom-heard communities: 85% of PCN teams agreed that the Health Innovation Network patient-facing resources helped them engage with target communities. Specific examples include improved engagement with veterans, people with a learning disability, and those with English as a second language.

Catalyst for pathway improvement: The project provided a structured opportunity for PCNs to review their SMR processes, including patient identification, screening, pre-SMR work, and time allocation. Some PCNs designed new SMR pathways or moved from reactive to proactive approaches.

Value of patient resources: The Health Innovation Network SMR resources, which were funded by NHS England, were appreciated by both patients and healthcare professionals, particularly the improved quality of conversations and shared decision making. The availability of resources in 12 community languages and easy-read versions was particularly helpful in engaging diverse patient groups.

The role of pharmacists: The initiative reinforced the value of the pharmacist's role in multidisciplinary teams and their knowledge. Pharmacists carried out SMRs in almost all participating PCNs, often with dedicated time allocations.

Funding as an enabler: Although small, the funding, was seen as a significant enabler, creating dedicated time for PCNs to think about and deliver SMRs.

Enhanced patient understanding and preparation: Half of respondents felt the materials helped patients better understand and prepare for their SMR, leading to improved quality of the review and increased likelihood of patients asking questions.

Empowering patients: Patient feedback highlighted feelings of empowerment, valuing time for preparation, and appreciating receiving resources in their own language. Patients reported feeling more confident talking to their GP or pharmacist after reading the materials.


Useful links






Meet our Innovation adoption team

How can we help you?

If you’d like to get in touch please
email medicines.optimisation@hiwessex.net

More projects

See all projects

Case studies

See all case studies

Events

See all events

News

See all news

Videos & podcasts

See all videos & podcasts

Stay connected, sign up for
our monthly newsletter

Sign up now Funding newsletter